Skip to main content
Signal8

Coy Travis Alan

SEC insider (Form 3/4/5 filer). CIK 0001969524. Director at TRex Bio, Inc. (TRXB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Coy Travis Alan has filed insider reports for

  • TRex Bio, Inc. (TRXB): Director
  • Immunocore Holdings plc (IMCR): Officer, Chief Financial Officer
Coy Travis Alan profile photo

Coy Travis Alan

CIK: 0001969524

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TRex Bio, Inc. logo
TRXB

TRex Bio, Inc.

Director
Immunocore Holdings plc logo
IMCR

Immunocore Holdings plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • TRex Bio, Inc. logo
    TRXB

    TRex Bio, Inc.

    Oct 8, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    17.5K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2026
    Award

    Restricted Share Units

    Direct
    33.4K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Feb 17, 2026
    Award

    Employee Share Option (Right to Buy)

    Direct
    95.6K shares-
  • Immunocore Holdings plc logo
    IMCR

    Immunocore Holdings plc

    Jan 1, 2025
    Award

    Employee Share Option (Right to Buy)

    Direct
    274K shares-

1-4 of 4